BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Spero Therapeutics Inc.

Headquarters: Cambridge, MA, United States
Year Founded: 2013
Status: Public
Industry Sector: HealthTechnology
CEO: Esther Rajavelu, MBA
Number Of Employees: 32
Enterprise Value: $7,067,055
PE Ratio: -0.45
Exchange/Ticker 1: NASDAQ:SPRO
Exchange/Ticker 2: N/A
Latest Market Cap: $32,148,602